Drug Delivery Technology Development in Canada

Kishor Wasan, Ildiko Badea (Herausgeber)

Buch | Softcover

352 Seiten

2019
MDPI (Verlag)
978-3-03928-004-9 (ISBN)

Keine Verlagsinformationen verfügbar

Artikel merken

Canada continues to have a rich history of ground-breaking research in drug delivery within academic institutions, pharmaceutical industry and the biotechnology community. Over the past 30 years, numerous Canadian-based biotechnology companies have been formed from the inventions conceived and developed within academic institutions that have led to the development of important drug delivery products that have enhanced the landscape of drug therapy in the treatment of cancer to infectious diseases.
This Special Issue serves to highlight and capture the contemporary progress of drug delivery within the prevailing Canadian context. We invite articles on all aspects of drug delivery sciences from pre-clinical formulation development to human clinical trials that bring to light the world-class research currently undertaken in Canada for this Special Issue.

Erscheinungsdatum	24.12.2019
Verlagsort	Basel
Sprache	englisch
Maße	170 x 244 mm
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
Themenwelt	Naturwissenschaften ► Chemie ► Allgemeines / Lexika
Schlagworte	3D spheroid • adenanthin • amphotericin B • antibodies • Bacteriophage • bioaccessibility • Biodistribution • Biological barriers • Biologicals • blood-brain barrier • blood-brain barrier (BBB) • Canada • Cancer • canola oil deodorizer distillate • cationic gemini surfactant • child friendly formulation • Chronotherapy • Circadian clock • Cisplatin • Clinical Trials • co-delivery • Combination Therapy • Controlled drug delivery • developing world • Dissolution • Doxorubicin • DOX-Vit D • Drug Delivery • Drug Delivery Systems • drug development • drug discovery • drug-resistant melanoma • EGFR-targeted therapy • Emulsion • encapsulation • flavonoids • formulation and dosage form development • Fungal Infections • gambogic acid • gastrointestinal simulator • GE11 peptide • HAV6 cadherin peptide • HIF-1 • hypoxia-induced chemoresistance • inclusion complex • Innovation • Intra-arterial Chemotherapy • Lipid nanoparticles • Liposome • Liposomes • loading gradients • magnetic fields • Magnetic Resonance Imaging (MRI) • malignant gliomas • Medical Devices • Medulloblastoma • Mefloquine • Melphalan • Metaplex • MG63 • model orange juice • Mouse Models • nanoparticles • nifedipine • oral delivery • oral formulation • oral, head and neck squamous cell carcinoma • Parasitic Infections • permeation enhancers • Phage Display • Pharmaceutics • Pharmacokinetics • pharmacological Inhibitors of HIF-1 and STAT3 • phospholipid complex • Photostabilizers • Phytosterols • Plant • Polymeric Micelle • Precision medicine • primary central nervous system lymphomas • Quercetin • Radiation • Radiolabeling • remote loading • ROESY NMR spectroscopy • rosmarinic acid • route of administration • Skin • small molecules • stat3 • staurosporine • sustained delivery • Targeted therapies • Throughput • TNO gastrointestinal model • Tocopherols • topical formulation • Transdermal Drug Delivery • transient modulation • Translational research • triggered drug release • Ultrasound • Virus • Vitamin D • water miscible solvents
ISBN-10	3-03928-004-X / 303928004X
ISBN-13	978-3-03928-004-9 / 9783039280049
Zustand	Neuware